{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:50:47Z","timestamp":1762325447038},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2020-I2M-CT-B-026"],"award-info":[{"award-number":["2020-I2M-CT-B-026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with non-alcoholic fatty liver disease (NAFLD) may be more susceptible to coronavirus disease 2019 (COVID-19) and even more likely to suffer from severe COVID-19. Whether there is a common molecular pathological basis for COVID-19 and NAFLD remains to be identified. The present study aimed to elucidate the transcriptional alterations shared by COVID-19 and NAFLD and to identify potential compounds targeting both diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Differentially expressed genes (DEGs) for COVID-19 and NAFLD were extracted from the GSE147507 and GSE89632 datasets, and common DEGs were identified using the Venn diagram. Subsequently, we constructed a protein\u2013protein interaction (PPI) network based on the common DEGs and extracted hub genes. Then, we performed gene ontology (GO) and pathway analysis of common DEGs. In addition, transcription factors (TFs) and miRNAs regulatory networks were constructed, and drug candidates were identified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified a total of 62 common DEGs for COVID-19 and NAFLD. The 10 hub genes extracted based on the PPI network were IL6, IL1B, PTGS2, JUN, FOS, ATF3, SOCS3, CSF3, NFKB2, and HBEGF. In addition, we also constructed TFs\u2013DEGs, miRNAs\u2013DEGs, and protein\u2013drug interaction networks, demonstrating the complex regulatory relationships of common DEGs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We successfully extracted 10 hub genes that could be used as novel therapeutic targets for COVID-19 and NAFLD. In addition, based on common DEGs, we propose some potential drugs that may benefit patients with COVID-19 and NAFLD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-022-00865-y","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T06:02:59Z","timestamp":1668492179000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systems biology approach reveals a common molecular basis for COVID-19 and non-alcoholic fatty liver disease (NAFLD)"],"prefix":"10.1186","volume":"27","author":[{"given":"Shi-Tao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Ge","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Ting","family":"Sang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Yao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"issue":"3","key":"865_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"C-C Lai","year":"2020","unstructured":"Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3): 105924.","journal-title":"Int J Antimicrob Agents"},{"key":"865_CR2","doi-asserted-by":"crossref","unstructured":"Soler ZM, Patel ZM, Turner JH, Holbrook EH. A primer on viral\u2010associated olfactory loss in the era of COVID\u201019. International Forum of Allergy & Rhinology: Wiley Online Library; 2020. p. 814\u201320.","DOI":"10.1002\/alr.22578"},{"issue":"7","key":"865_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S1473-3099(20)30195-X","volume":"20","author":"D Baud","year":"2020","unstructured":"Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;20(7):773.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"865_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12979-020-00192-y","volume":"17","author":"CH Mazucanti","year":"2020","unstructured":"Mazucanti CH, Egan JM. SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done? Immunity Ageing. 2020;17(1):21. https:\/\/doi.org\/10.1186\/s12979-020-00192-y.","journal-title":"Immunity Ageing"},{"issue":"2","key":"865_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","volume":"73","author":"D Ji","year":"2020","unstructured":"Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, et al. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. 2020;73(2):451\u20133.","journal-title":"J Hepatol"},{"key":"865_CR6","first-page":"56","volume":"89","author":"L Hartl","year":"2019","unstructured":"Hartl L, Haslinger K, Angerer M, Semmler G, Schneeweiss-Gleixner M, Jachs M, et al. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in chronic liver disease patients. Hepatology. 2019;89:56.","journal-title":"Hepatology"},{"issue":"6","key":"865_CR7","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69(6):2672\u201382.","journal-title":"Hepatology"},{"issue":"4","key":"865_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u201338.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"865_CR9","first-page":"661","volume":"8","author":"N Alkhouri","year":"2012","unstructured":"Alkhouri N, McCullough AJ. Noninvasive diagnosis of NASH and liver fibrosis within the spectrum of NAFLD. Gastroenterol Hepatol. 2012;8(10):661.","journal-title":"Gastroenterol Hepatol"},{"key":"865_CR10","first-page":"1","volume":"89","author":"T Huby","year":"2021","unstructured":"Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2021;89:1\u201315.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"865_CR11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jhep.2020.12.007","volume":"74","author":"AS Meijnikman","year":"2021","unstructured":"Meijnikman AS, Bruin S, Groen AK, Nieuwdorp M, Herrema H. Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD. J Hepatol. 2021;74(3):748\u20139.","journal-title":"J Hepatol"},{"issue":"2","key":"865_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","volume":"73","author":"D Ji","year":"2020","unstructured":"Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, et al. Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis. J Hepatol. 2020;73(2):451\u20133.","journal-title":"J Hepatol"},{"issue":"5","key":"865_CR13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, M\u00f8ller R, et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181(5):1036-45.e9. https:\/\/doi.org\/10.1016\/j.cell.2020.04.026.","journal-title":"Cell"},{"issue":"5","key":"865_CR14","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/hep.27695","volume":"61","author":"BM Arendt","year":"2015","unstructured":"Arendt BM, Comelli EM, Ma DW, Lou W, Teterina A, Kim T, et al. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids. Hepatology. 2015;61(5):1565\u201378.","journal-title":"Hepatology"},{"issue":"3","key":"865_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z, Bailey A, Kuleshov MV, Clarke DJ, Evangelista JE, Jenkins SL, et al. Gene set knowledge discovery with enrichr. Current Protocols. 2021;1(3): e90.","journal-title":"Current Protocols"},{"issue":"D1","key":"865_CR16","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49(D1):D605\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"865_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2011","unstructured":"Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431\u20132.","journal-title":"Bioinformatics"},{"issue":"1","key":"865_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-017-1576-1","volume":"18","author":"D Yu","year":"2017","unstructured":"Yu D, Lim J, Wang X, Liang F, Xiao G. Enhanced construction of gene regulatory networks using hub gene information. BMC Bioinformatics. 2017;18(1):1\u201320.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"865_CR19","first-page":"1","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(4):1\u20137.","journal-title":"BMC Syst Biol"},{"issue":"1","key":"865_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"C Li","year":"2019","unstructured":"Li C, Xu J. Feature selection with the Fisher score followed by the Maximal Clique Centrality algorithm can accurately identify the hub genes of hepatocellular carcinoma. Sci Rep. 2019;9(1):1\u201311.","journal-title":"Sci Rep"},{"issue":"3","key":"865_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00438-013-0734-z","volume":"288","author":"S Arora","year":"2013","unstructured":"Arora S, Rana R, Chhabra A, Jaiswal A, Rani V. miRNA\u2013transcription factor interactions: a combinatorial regulation of gene expression. Mol Genet Genomics. 2013;288(3):77\u201387.","journal-title":"Mol Genet Genomics"},{"issue":"1","key":"865_CR22","doi-asserted-by":"publisher","first-page":"D91","DOI":"10.1093\/nar\/gkh012","volume":"32","author":"A Sandelin","year":"2004","unstructured":"Sandelin A, Alkema W, Engstr\u00f6m P, Wasserman WW, Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 2004;32(1):D91\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"865_CR23","doi-asserted-by":"publisher","first-page":"W167","DOI":"10.1093\/nar\/gku443","volume":"42","author":"J Xia","year":"2014","unstructured":"Xia J, Benner MJ, Hancock RE. NetworkAnalyst-integrative approaches for protein\u2013protein interaction network analysis and visual exploration. Nucleic Acids Res. 2014;42(W1):W167\u201374.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"865_CR24","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou G, Soufan O, Ewald J, Hancock RE, Basu N, Xia J. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47(W1):W234\u201341.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"865_CR25","first-page":"D148","volume":"48","author":"H-Y Huang","year":"2020","unstructured":"Huang H-Y, Lin YCD, Li J, Huang K-Y, Shrestha S, Hong H-C, et al. miRTarBase 2020: updates to the experimentally validated microRNA\u2013target interaction database. Nucleic Acids Res. 2020;48(D1):D148\u201354.","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"865_CR26","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, et al. DSigDB: drug signatures database for gene set analysis. Bioinformatics. 2015;31(18):3069\u201371.","journal-title":"Bioinformatics"},{"key":"865_CR27","first-page":"943","volume":"67","author":"J Pi\u00f1ero","year":"2016","unstructured":"Pi\u00f1ero J, Bravo \u00c0, Queralt-Rosinach N, Guti\u00e9rrez-Sacrist\u00e1n A, Deu-Pons J, Centeno E, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2016;67:943.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"865_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.dsx.2021.03.019","volume":"15","author":"A Singh","year":"2021","unstructured":"Singh A, Hussain S, Antony B. Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: a comprehensive systematic review and meta-analysis. Diabetes Metab Syndr. 2021;15(3):813\u201322.","journal-title":"Diabetes Metab Syndr"},{"issue":"10","key":"865_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240400","volume":"15","author":"R Forlano","year":"2020","unstructured":"Forlano R, Mullish BH, Mukherjee SK, Nathwani R, Harlow C, Crook P, et al. In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19. PLoS ONE. 2020;15(10): e0240400.","journal-title":"PLoS ONE"},{"issue":"7","key":"865_CR30","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/hep4.1745","volume":"5","author":"MA Martinez","year":"2021","unstructured":"Martinez MA, Franco S. Impact of COVID-19 in Liver Disease Progression. Hepatology Communications. 2021;5(7):1138\u201350. https:\/\/doi.org\/10.1002\/hep4.1745.","journal-title":"Hepatology Communications"},{"key":"865_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.626425","volume":"8","author":"PJ Hegyi","year":"2021","unstructured":"Hegyi PJ, V\u00e1ncsa S, Ocskay K, Dembrovszky F, Kiss S, Farkas N, et al. Metabolic associated fatty liver disease is associated with an increased risk of severe COVID-19: a systematic review with meta-analysis. Front Med. 2021;8: 626425.","journal-title":"Front Med"},{"key":"865_CR32","first-page":"4","volume":"89","author":"CT Bramante","year":"2020","unstructured":"Bramante CT, Tignanelli CJ, Dutta N, Jones E, Tamaritz L, Clark J, et al. Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19. MedRxiv. 2020;89:4.","journal-title":"MedRxiv."},{"issue":"1","key":"865_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41420-022-00998-3","volume":"8","author":"Y Wu","year":"2022","unstructured":"Wu Y, Zhang J, Yu S, Li Y, Zhu J, Zhang K, et al. Cell pyroptosis in health and inflammatory diseases. Cell Death Discovery. 2022;8(1):191. https:\/\/doi.org\/10.1038\/s41420-022-00998-3.","journal-title":"Cell Death Discovery"},{"issue":"10","key":"865_CR34","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26(10):1636\u201343.","journal-title":"Nat Med"},{"issue":"23","key":"865_CR35","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383(23):2255\u201373.","journal-title":"N Engl J Med"},{"key":"865_CR36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1055\/a-1834-9008","volume":"54","author":"C Hoffmann","year":"2022","unstructured":"Hoffmann C, Gerber PA, Cavelti-Weder C, Licht L, Kotb R, Al Dweik R, et al. Liver, NAFLD and COVID-19. Hormone Metab Res. 2022;54:522.","journal-title":"Hormone Metab Res."},{"issue":"10","key":"865_CR37","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/medicina57101057","volume":"57","author":"L Vrani\u0107","year":"2021","unstructured":"Vrani\u0107 L, Radovan A, Poropat G, Mikola\u0161evi\u0107 I, Mili\u0107 S. Non-alcoholic fatty liver disease and COVID-19\u2013two pandemics hitting at the same time. Medicina. 2021;57(10):1057.","journal-title":"Medicina"},{"issue":"1","key":"865_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24360-w","volume":"12","author":"L Vanderbeke","year":"2021","unstructured":"Vanderbeke L, Van Mol P, Van Herck Y, De Smet F, Humblet-Baron S, Martinod K, et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun. 2021;12(1):1\u201315.","journal-title":"Nat Commun"},{"issue":"1","key":"865_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12865-020-00358-9","volume":"21","author":"Z Lu","year":"2020","unstructured":"Lu Z, He B, Chen Z, Yan M, Wu L. Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway. BMC Immunol. 2020;21(1):1\u20139.","journal-title":"BMC Immunol"},{"issue":"5","key":"865_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/bib\/bbab115","volume":"22","author":"SH Mahmud","year":"2021","unstructured":"Mahmud SH, Al-Mustanjid M, Akter F, Rahman MS, Ahmed K, Rahman MH, et al. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients. Briefings Bioinform. 2021;22(5):115.","journal-title":"Briefings Bioinform"},{"issue":"D1","key":"865_CR41","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gky962","volume":"47","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M, Sato Y, Furumichi M, Morishima K, Tanabe M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 2019;47(D1):D590\u20135.","journal-title":"Nucleic Acids Res"},{"key":"865_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118054","volume":"257","author":"SM Abdin","year":"2020","unstructured":"Abdin SM, Elgendy SM, Alyammahi SK, Alhamad DW, Omar HA. Tackling the cytokine storm in COVID-19, challenges and hopes. Life Sci. 2020;257: 118054.","journal-title":"Life Sci"},{"issue":"1","key":"865_CR43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.medj.2020.11.005","volume":"1","author":"PC Robinson","year":"2020","unstructured":"Robinson PC, Liew DF, Liew JW, Monaco C, Richards D, Shivakumar S, et al. The potential for repurposing anti-TNF as a therapy for the treatment of COVID-19. Med. 2020;1(1):90\u2013102.","journal-title":"Med"},{"issue":"11","key":"865_CR44","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41575-021-00473-x","volume":"18","author":"MD Giraldez","year":"2021","unstructured":"Giraldez MD, Carneros D, Garbers C, Rose-John S, Bustos M. New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology. Nat Rev Gastroenterol Hepatol. 2021;18(11):787\u2013803.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"865_CR45","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jaci.2020.07.001","volume":"146","author":"A Copaescu","year":"2020","unstructured":"Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J Allergy Clin Immunol. 2020;146(3):518\u201334.","journal-title":"J Allergy Clin Immunol"},{"key":"865_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cytogfr.2020.05.009","volume":"53","author":"E Gubernatorova","year":"2020","unstructured":"Gubernatorova E, Gorshkova E, Polinova A, Drutskaya M. IL-6: Relevance for immunopathology of SARS-CoV-2. Cytokine Growth Factor Rev. 2020;53:13\u201324.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"865_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","volume":"30","author":"EA Coomes","year":"2020","unstructured":"Coomes EA, Haghbayan H. Interleukin-6 in COVID-19: a systematic review and meta-analysis. Rev Med Virol. 2020;30(6):1\u20139.","journal-title":"Rev Med Virol"},{"issue":"12","key":"865_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009128","volume":"16","author":"T Patra","year":"2020","unstructured":"Patra T, Meyer K, Geerling L, Isbell TS, Hoft DF, Brien J, et al. SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells. PLoS Pathog. 2020;16(12): e1009128.","journal-title":"PLoS Pathog"},{"issue":"7847","key":"865_CR49","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41586-020-03148-w","volume":"590","author":"RA Grant","year":"2021","unstructured":"Grant RA, Morales-Nebreda L, Markov NS, Swaminathan S, Querrey M, Guzman ER, et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature. 2021;590(7847):635\u201341.","journal-title":"Nature"},{"issue":"1","key":"865_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-020-01343-z","volume":"20","author":"L Pandolfi","year":"2020","unstructured":"Pandolfi L, Fossali T, Frangipane V, Bozzini S, Morosini M, D\u2019Amato M, et al. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome. BMC Pulm Med. 2020;20(1):1\u201310.","journal-title":"BMC Pulm Med"},{"issue":"6","key":"865_CR51","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LF. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"865_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"L Tan","year":"2020","unstructured":"Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang Y-Q, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5(1):1\u20133.","journal-title":"Signal Transduct Target Ther"},{"key":"865_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118097","volume":"257","author":"M Abbasifard","year":"2020","unstructured":"Abbasifard M, Khorramdelazad H. The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics. Life Sci. 2020;257: 118097.","journal-title":"Life Sci"},{"issue":"11","key":"865_CR54","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1021\/acs.jproteome.0c00365","volume":"19","author":"A D\u2019Alessandro","year":"2020","unstructured":"D\u2019Alessandro A, Thomas T, Dzieciatkowska M, Hill RC, Francis RO, Hudson KE, et al. Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level. J Proteome Res. 2020;19(11):4417\u201327.","journal-title":"J Proteome Res"},{"key":"865_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.604100","volume":"12","author":"F Gao","year":"2021","unstructured":"Gao F, Zheng KI, Yan H-D, Sun Q-F, Pan K-H, Wang T-Y, et al. Association and interaction between serum interleukin-6 levels and metabolic dysfunction-associated fatty liver disease in patients with severe coronavirus disease 2019. Front Endocrinol. 2021;12: 604100.","journal-title":"Front Endocrinol"},{"issue":"3","key":"865_CR56","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jhep.2021.04.050","volume":"75","author":"MJ McConnell","year":"2021","unstructured":"McConnell MJ, Kawaguchi N, Kondo R, Sonzogni A, Licini L, Valle C, et al. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy. J Hepatol. 2021;75(3):647\u201358.","journal-title":"J Hepatol"},{"issue":"2","key":"865_CR57","first-page":"11","volume":"34","author":"E Toniato","year":"2020","unstructured":"Toniato E, Ross R, Kritas S. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 2020;34(2):11\u20136.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"865_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281(1):8\u201327. https:\/\/doi.org\/10.1111\/imr.12621.","journal-title":"Immunol Rev"},{"issue":"1","key":"865_CR59","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s13054-020-03166-0","volume":"24","author":"FL van de Veerdonk","year":"2020","unstructured":"van de Veerdonk FL, Netea MG. Blocking IL-1 to prevent respiratory failure in COVID-19. Crit Care. 2020;24(1):445. https:\/\/doi.org\/10.1186\/s13054-020-03166-0.","journal-title":"Crit Care"},{"issue":"4","key":"865_CR60","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1165\/rcmb.2004-0309OC","volume":"32","author":"U Lappalainen","year":"2005","unstructured":"Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K. Interleukin-1\u03b2 causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol. 2005;32(4):311\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6\u20137","key":"865_CR61","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ejcb.2011.09.008","volume":"91","author":"JG Bode","year":"2012","unstructured":"Bode JG, Albrecht U, H\u00e4ussinger D, Heinrich PC, Schaper F. Hepatic acute phase proteins\u2013regulation by IL-6-and IL-1-type cytokines involving STAT3 and its crosstalk with NF-\u03baB-dependent signaling. Eur J Cell Biol. 2012;91(6\u20137):496\u2013505.","journal-title":"Eur J Cell Biol"},{"issue":"5","key":"865_CR62","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha AR, Wree A, Robertson AA, Yeh MM, Johnson CD, Van Rooyen DM, et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol. 2017;66(5):1037\u201346.","journal-title":"J Hepatol"},{"issue":"16","key":"865_CR63","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.1073\/pnas.89.16.7384","volume":"89","author":"T Hla","year":"1992","unstructured":"Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci. 1992;89(16):7384\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"865_CR64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijid.2020.09.1466","volume":"101","author":"S Baghaki","year":"2020","unstructured":"Baghaki S, Yalcin CE, Baghaki HS, Aydin SY, Daghan B, Yavuz E. COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies. Int J Infect Dis. 2020;101:29\u201332.","journal-title":"Int J Infect Dis"},{"key":"865_CR65","first-page":"55","volume":"45","author":"JS Chen","year":"2020","unstructured":"Chen JS, Alfajaro MM, Wei J, Chow RD, Filler RB, Eisenbarth SC, et al. Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication. BioRxiv. 2020;45:55.","journal-title":"BioRxiv."},{"issue":"11","key":"865_CR66","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00228-020-02941-w","volume":"76","author":"M Hoxha","year":"2020","unstructured":"Hoxha M. What about COVID-19 and arachidonic acid pathway? Eur J Clin Pharmacol. 2020;76(11):1501\u20134.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"865_CR67","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/oby.2008.674","volume":"17","author":"PS Hsieh","year":"2009","unstructured":"Hsieh PS, Jin JS, Chiang CF, Chan PC, Chen CH, Shih KC. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity. 2009;17(6):1150\u20137.","journal-title":"Obesity"},{"issue":"13","key":"865_CR68","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.3390\/ijms20133115","volume":"20","author":"P-C Chan","year":"2019","unstructured":"Chan P-C, Liao M-T, Hsieh P-S. The dualistic effect of COX-2-mediated signaling in obesity and insulin resistance. Int J Mol Sci. 2019;20(13):3115.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"865_CR69","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrc1209","volume":"3","author":"R Eferl","year":"2003","unstructured":"Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003;3(11):859\u201368.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"865_CR70","first-page":"5484","volume":"17","author":"X Liu","year":"2018","unstructured":"Liu X, Yin S, Chen Y, Wu Y, Zheng W, Dong H, et al. LPS-induced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NF-\u03baB, STAT3 or AP-1 activation. Mol Med Rep. 2018;17(4):5484\u201391.","journal-title":"Mol Med Rep"},{"key":"865_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.589380","volume":"11","author":"B Kalfaoglu","year":"2020","unstructured":"Kalfaoglu B, Almeida-Santos J, Tye CA, Satou Y, Ono M. T-cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis. Front Immunol. 2020;11: 589380.","journal-title":"Front Immunol"},{"issue":"1","key":"865_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109793","volume":"37","author":"N Liu","year":"2021","unstructured":"Liu N, Jiang C, Cai P, Shen Z, Sun W, Xu H, et al. Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes. Cell Rep. 2021;37(1): 109793.","journal-title":"Cell Rep"},{"key":"865_CR73","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1155\/2020\/8468303","volume":"2020","author":"Y Wang","year":"2020","unstructured":"Wang Y, Ru Y, Zhuo G, Sheng M, Wang S, Ma J, et al. Investigation of the potential mechanism governing the effect of the Shen Zhu san on COVID-19 by network pharmacology. Evid-Based Complement Altern Med. 2020;2020:8.","journal-title":"Evid-Based Complement Altern Med"},{"issue":"1","key":"865_CR74","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/1097-0142(20010101)91:1<106::AID-CNCR14>3.0.CO;2-2","volume":"91","author":"MF Yuen","year":"2001","unstructured":"Yuen MF, Wu PC, Lai VCH, Lau JYN, Lai CL. Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma. Cancer. 2001;91(1):106\u201312.","journal-title":"Cancer"},{"issue":"2","key":"865_CR75","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jhep.2017.03.023","volume":"67","author":"JY Kim","year":"2017","unstructured":"Kim JY, Park KJ, Hwang J-Y, Kim GH, Lee D, Lee YJ, et al. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis. J Hepatol. 2017;67(2):349\u201359.","journal-title":"J Hepatol"},{"issue":"8","key":"865_CR76","doi-asserted-by":"publisher","first-page":"13242","DOI":"10.1002\/jcp.27996","volume":"234","author":"X Chi","year":"2019","unstructured":"Chi X, Ding B, Zhang L, Zhang J, Wang J, Zhang W. lncRNA GAS5 promotes M1 macrophage polarization via miR-455-5p\/SOCS3 pathway in childhood pneumonia. J Cell Physiol. 2019;234(8):13242\u201351.","journal-title":"J Cell Physiol"},{"key":"865_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.582102","volume":"11","author":"HM Johnson","year":"2020","unstructured":"Johnson HM, Lewin AS, Ahmed CM. SOCS, intrinsic virulence factors, and treatment of COVID-19. Front Immunol. 2020;11: 582102.","journal-title":"Front Immunol"},{"key":"865_CR78","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.trsl.2016.06.003","volume":"177","author":"N Sahini","year":"2016","unstructured":"Sahini N, Borlak J. Genomics of human fatty liver disease reveal mechanistically linked lipid droplet\u2013associated gene regulations in bland steatosis and nonalcoholic steatohepatitis. Transl Res. 2016;177:41\u201369.","journal-title":"Transl Res"},{"issue":"2","key":"865_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112204","volume":"395","author":"G Nunnari","year":"2020","unstructured":"Nunnari G, Sanfilippo C, Castrogiovanni P, Imbesi R, Volti GL, Barbagallo I, et al. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection. Exp Cell Res. 2020;395(2): 112204.","journal-title":"Exp Cell Res"},{"key":"865_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.605792","volume":"11","author":"C Fang","year":"2021","unstructured":"Fang C, Mei J, Tian H, Liou Y-L, Rong D, Zhang W, et al. CSF3 is a potential drug target for the treatment of COVID-19. Front Physiol. 2021;11: 605792.","journal-title":"Front Physiol"},{"key":"865_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.06.847","volume":"263","author":"I Doulamis","year":"2017","unstructured":"Doulamis I, Tzani A, Konstantopoulos P, Antoranz A, Plakia V, Minia A, et al. Targeted proteomics identification of biomarkers for diabetes mellitus in patients with cardiovascular disease. Atherosclerosis. 2017;263: e261.","journal-title":"Atherosclerosis"},{"issue":"6504","key":"865_CR82","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718\u201324.","journal-title":"Science"},{"key":"865_CR83","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3346\/jkms.2020.35.e343","volume":"35","author":"KM Sohn","year":"2020","unstructured":"Sohn KM, Lee S-G, Kim HJ, Cheon S, Jeong H, Lee J, et al. COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis. J Korean Med Sci. 2020;35:38.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"865_CR84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"L Leng","year":"2020","unstructured":"Leng L, Cao R, Ma J, Mou D, Zhu Y, Li W, et al. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples. Signal Transduct Target Ther. 2020;5(1):1\u20139.","journal-title":"Signal Transduct Target Ther"},{"key":"865_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.598444","volume":"11","author":"R Kircheis","year":"2020","unstructured":"Kircheis R, Haasbach E, Lueftenegger D, Heyken WT, Ocker M, Planz O. NF-\u03baB pathway as a potential target for treatment of critical stage COVID-19 patients. Front Immunol. 2020;11: 598444.","journal-title":"Front Immunol"},{"issue":"10","key":"865_CR86","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/cells8101222","volume":"8","author":"AN Malik","year":"2019","unstructured":"Malik AN, Sim\u00f5es IC, Rosa HS, Khan S, Karkucinska-Wieckowska A, Wieckowski MR. A diet induced maladaptive increase in hepatic mitochondrial DNA precedes OXPHOS defects and may contribute to non-alcoholic fatty liver disease. Cells. 2019;8(10):1222.","journal-title":"Cells"},{"issue":"12","key":"865_CR87","doi-asserted-by":"publisher","first-page":"e00182","DOI":"10.1128\/JVI.00182-17","volume":"91","author":"T Venkataraman","year":"2017","unstructured":"Venkataraman T, Coleman CM, Frieman MB. Overactive epidermal growth factor receptor signaling leads to increased fibrosis after severe acute respiratory syndrome coronavirus infection. J Virol. 2017;91(12):e00182-e217.","journal-title":"J Virol"},{"issue":"1","key":"865_CR88","first-page":"17101","volume":"138","author":"S Kim","year":"2018","unstructured":"Kim S, Yang L, Temel RE, Lee RG, Graham MJ, Lee S. Targeting of Heparin-Binding EGF-Like Growth Factor (HB-EGF) effectively protected against hyperlipidemia-associated vascular and hepatic inflammations. Circulation. 2018;138(1):17101.","journal-title":"Circulation"},{"issue":"4","key":"865_CR89","first-page":"402","volume":"37","author":"XQ Fan","year":"2021","unstructured":"Fan XQ, Li H, Zhu HX, Huang JP, He LF. Effects of miR-335\u20135p targeting G6PD on proliferation and apoptosis of colon cancer cells. Chin J Appl Physiol. 2021;37(4):402\u20136.","journal-title":"Chin J Appl Physiol"},{"issue":"1","key":"865_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-017-0637-2","volume":"17","author":"J Zhang","year":"2017","unstructured":"Zhang J, Fan J, Zhou C, Qi Y. miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA. BMC Gastroenterol. 2017;17(1):1\u20139.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"865_CR91","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","volume":"5","author":"PN Newsome","year":"2020","unstructured":"Newsome PN, Sasso M, Deeks JJ, Paredes A, Boursier J, Chan W-K, et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. The lancet Gastroenterology & hepatology. 2020;5(4):362\u201373.","journal-title":"The lancet Gastroenterology & hepatology"},{"issue":"4","key":"865_CR92","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.1080\/21655979.2022.2026858","volume":"13","author":"J Cui","year":"2022","unstructured":"Cui J, Wang Y, Xue H. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p\/NOTCH2 axis. Bioengineered. 2022;13(4):8370\u201381.","journal-title":"Bioengineered"},{"issue":"6","key":"865_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.200","volume":"10","author":"H Tang","year":"2020","unstructured":"Tang H, Gao Y, Li Z, Miao Y, Huang Z, Liu X, et al. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19. Clin Transl Med. 2020;10(6): e200.","journal-title":"Clin Transl Med"},{"issue":"1","key":"865_CR94","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jvh.13440","volume":"28","author":"G Cabibbo","year":"2021","unstructured":"Cabibbo G, Rizzo GEM, Stornello C, Crax\u00ec A. SARS-CoV-2 infection in patients with a normal or abnormal liver. J Viral Hepatitis. 2021;28(1):4\u201311.","journal-title":"J Viral Hepatitis"},{"issue":"6","key":"865_CR95","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S2215-0366(20)30168-1","volume":"7","author":"EA Holmes","year":"2020","unstructured":"Holmes EA, O\u2019Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7(6):547\u201360.","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"865_CR96","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamainternmed.2020.1562","volume":"180","author":"S Galea","year":"2020","unstructured":"Galea S, Merchant RM, Lurie N. The mental health consequences of COVID-19 and physical distancing: the need for prevention and early intervention. JAMA Intern Med. 2020;180(6):817\u20138.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"865_CR97","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ijgo.13287","volume":"151","author":"P Yal\u00e7\u0131n Bahat","year":"2020","unstructured":"Yal\u00e7\u0131n Bahat P, Ald\u0131ka\u00e7t\u0131o\u011flu Talma\u00e7 M, Bestel A, Topbas Selcuki NF, Karadeniz O, Polat I. Evaluating the effects of the COVID-19 pandemic on the physical and mental well-being of obstetricians and gynecologists in Turkey. Int J Gynecol Obstet. 2020;151(1):67\u201373.","journal-title":"Int J Gynecol Obstet"},{"issue":"6","key":"865_CR98","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.clindermatol.2020.03.012","volume":"38","author":"R Darlenski","year":"2020","unstructured":"Darlenski R, Tsankov N. COVID-19 pandemic and the skin: what should dermatologists know? Clin Dermatol. 2020;38(6):785\u20137.","journal-title":"Clin Dermatol"},{"issue":"2","key":"865_CR99","doi-asserted-by":"publisher","first-page":"731","DOI":"10.7150\/thno.51471","volume":"11","author":"AS Pathania","year":"2021","unstructured":"Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, et al. COVID-19 and cancer comorbidity: therapeutic opportunities and challenges. Theranostics. 2021;11(2):731.","journal-title":"Theranostics"},{"key":"865_CR100","first-page":"9","volume":"56","author":"T-Y Xiong","year":"2020","unstructured":"Xiong T-Y, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020;56:9.","journal-title":"Eur Heart J"},{"key":"865_CR101","first-page":"67","volume":"45","author":"RE Jordan","year":"2020","unstructured":"Jordan RE, Adab P, Cheng K. Covid-19: risk factors for severe disease and death. Br Med J. 2020;45:67.","journal-title":"Br Med J"},{"issue":"3","key":"865_CR102","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335\u20137.","journal-title":"Lancet Oncol"},{"issue":"19","key":"865_CR103","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19. N Engl J Med. 2020;383(19):1813\u201326.","journal-title":"N Engl J Med"},{"key":"865_CR104","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijid.2020.10.069","volume":"102","author":"S Joshi","year":"2021","unstructured":"Joshi S, Parkar J, Ansari A, Vora A, Talwar D, Tiwaskar M, et al. Role of favipiravir in the treatment of COVID-19. Int J Infect Dis. 2021;102:501\u20138.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"865_CR105","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A JaykBernal","year":"2022","unstructured":"JaykBernal A, GomesdaSilva MM, Musungaie DB, Kovalchuk E, Gonzalez A, DelosReyes V, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med. 2022;386(6):509\u201320.","journal-title":"N Engl J Med"},{"issue":"1","key":"865_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","volume":"56","author":"P Gautret","year":"2020","unstructured":"Gautret P, Lagier J-C, Parola P, Meddeb L, Mailhe M, Doudier B, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1): 105949.","journal-title":"Int J Antimicrob Agents"},{"key":"865_CR107","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cmi.2020.08.022","volume":"27","author":"T Fiolet","year":"2020","unstructured":"Fiolet T, Guihur A, Rebeaud M, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y. Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis. Clin Microbiol Infect. 2020;27:19\u201327.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"865_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-72879-7","volume":"10","author":"J Cho","year":"2020","unstructured":"Cho J, Lee YJ, Kim JH, Kim SS, Choi B-S, Choi J-H. Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19. Sci Rep. 2020;10(1):1\u20138.","journal-title":"Sci Rep"},{"issue":"1","key":"865_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-01690-9","volume":"11","author":"H Caohuy","year":"2021","unstructured":"Caohuy H, Eidelman O, Chen T, Liu S, Yang Q, Bera A, et al. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells. Sci Rep. 2021;11(1):1\u201314.","journal-title":"Sci Rep"},{"issue":"2","key":"865_CR110","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4143\/crt.2018.060","volume":"51","author":"HJ Son","year":"2019","unstructured":"Son HJ, Sohn SH, Kim N, Lee H-N, Lee SM, Nam RH, et al. Effect of estradiol in an azoxymethane\/dextran sulfate sodium-treated mouse model of colorectal cancer: implication for sex difference in colorectal cancer development. Cancer Res Treatment. 2019;51(2):632\u201348.","journal-title":"Cancer Res Treatment"},{"issue":"6","key":"865_CR111","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1049\/syb2.12034","volume":"15","author":"W Deng","year":"2021","unstructured":"Deng W, Zeng J, Lu S, Li C. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome. IET Syst Biol. 2021;15(6):205\u201318.","journal-title":"IET Syst Biol"},{"key":"865_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104668","volume":"136","author":"MB Islam","year":"2021","unstructured":"Islam MB, Chowdhury UN, Nain Z, Uddin S, Ahmed MB, Moni MA. Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes. Comput Biol Med. 2021;136: 104668.","journal-title":"Comput Biol Med"},{"key":"865_CR113","first-page":"9","volume":"45","author":"DK Ngan","year":"2022","unstructured":"Ngan DK, Xu T, Xia M, Zheng W, Huang R. Repurposing drugs as COVID-19 therapies: A toxicity evaluation. Drug Discovery Today. 2022;45:9.","journal-title":"Drug Discovery Today"},{"issue":"1","key":"865_CR114","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/bib\/bbab373","volume":"23","author":"H Wang","year":"2022","unstructured":"Wang H, Zhang J, Lu Z, Dai W, Ma C, Xiang Y, et al. Identification of potential therapeutic targets and mechanisms of COVID-19 through network analysis and screening of chemicals and herbal ingredients. Briefings Bioinform. 2022;23(1):373.","journal-title":"Briefings Bioinform"},{"issue":"5","key":"865_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00284-022-02824-6","volume":"79","author":"N Ahmed","year":"2022","unstructured":"Ahmed N, Mahmood MS, Ullah M, Araf Y, Rahaman TI, Moin AT, et al. COVID-19-associated candidiasis: possible patho-mechanism, predisposing factors, and prevention strategies. Curr Microbiol. 2022;79(5):1\u201315.","journal-title":"Curr Microbiol"},{"key":"865_CR116","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2147\/TCRM.S195538","volume":"17","author":"H Yildiz","year":"2021","unstructured":"Yildiz H, Bailly S, Van Den Neste E, Yombi JC. Clinical management of relapsed\/refractory hemophagocytic lymphohistiocytosis in adult patients: a review of current strategies and emerging therapies. Ther Clin Risk Manag. 2021;17:293.","journal-title":"Ther Clin Risk Manag"},{"key":"865_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109826","volume":"142","author":"K Hamizi","year":"2020","unstructured":"Hamizi K, Aouidane S, Belaaloui G. Etoposide-based therapy for severe forms of COVID-19. Med Hypotheses. 2020;142: 109826.","journal-title":"Med Hypotheses"},{"issue":"1","key":"865_CR118","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.chest.2020.09.077","volume":"159","author":"M Patel","year":"2021","unstructured":"Patel M, Dominguez E, Sacher D, Desai P, Chandar A, Bromberg M, et al. Etoposide as salvage therapy for cytokine storm due to coronavirus disease 2019. Chest. 2021;159(1):e7\u201311.","journal-title":"Chest"},{"key":"865_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110180","volume":"144","author":"B Lovetrue","year":"2020","unstructured":"Lovetrue B. The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients. Med Hypotheses. 2020;144: 110180.","journal-title":"Med Hypotheses"},{"key":"865_CR120","first-page":"9","volume":"67","author":"M Valipour","year":"2022","unstructured":"Valipour M, Irannejad H, Emami S. Papaverine, a promising therapeutic agent for the treatment of COVID-19 patients with underlying cardiovascular diseases (CVDs). Drug Develop Res. 2022;67:9.","journal-title":"Drug Develop Res."},{"issue":"1","key":"865_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874091X02115010001","volume":"15","author":"C Hountondji","year":"2021","unstructured":"Hountondji C, Besna\u00efnou G, Gaudet E, Poupaert J. Repositioning adequate antibiotics to treat\/cure the coronavirus disease 2019 (COVID-19): current treatments and future directions. Open Biochem J. 2021;15(1):1\u201319.","journal-title":"Open Biochem J"},{"issue":"1","key":"865_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43088-021-00123-w","volume":"10","author":"B Nedjimi","year":"2021","unstructured":"Nedjimi B. Can trace element supplementations (Cu, Se, and Zn) enhance human immunity against COVID-19 and its new variants? Beni-Suef Univ J Basic Appl Sci. 2021;10(1):1\u20135.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"1","key":"865_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12011-017-1061-8","volume":"182","author":"MT Rahman","year":"2018","unstructured":"Rahman MT, Karim MM. Metallothionein: a potential link in the regulation of zinc in nutritional immunity. Biol Trace Elem Res. 2018;182(1):1\u201313.","journal-title":"Biol Trace Elem Res"},{"issue":"10","key":"865_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109180","volume":"9","author":"J Xue","year":"2014","unstructured":"Xue J, Moyer A, Peng B, Wu J, Hannafon BN, Ding W-Q. Chloroquine is a zinc ionophore. PLoS ONE. 2014;9(10): e109180.","journal-title":"PLoS ONE"},{"issue":"2","key":"865_CR125","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s12011-020-02194-9","volume":"199","author":"MT Rahman","year":"2021","unstructured":"Rahman MT, Idid SZ. Can Zn be a critical element in COVID-19 treatment? Biol Trace Elem Res. 2021;199(2):550\u20138.","journal-title":"Biol Trace Elem Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-022-00865-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T02:12:38Z","timestamp":1668651158000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-022-00865-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1186\/s40001-022-00865-y","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"7 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data involved in this article were obtained with permission from the GEO database. Since GEO is a public database, informed consent is waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors are strictly selected according to author criteria. No personal data was applicable in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}